Gestodene API (CAS No. 60282-87-3) is a synthetic steroidal progestin active pharmaceutical ingredient associated with hormonal contraceptive, reproductive health, and female hormone pharmaceutical development.
Gestodene is a potent synthetic progestogen belonging to the gonane class of steroidal progestins.
The compound acts primarily through interaction with progesterone receptors and produces progestogenic pharmacological activity.
Gestodene is commonly associated with combined oral contraceptive pharmaceutical products containing an estrogen component such as Ethinylestradiol.
The progestogenic activity of Gestodene contributes to suppression of gonadotropin-mediated ovulatory processes, changes in cervical mucus characteristics, and endometrial effects associated with hormonal contraceptive activity.
Gestodene is a highly stereochemically defined steroidal compound.
Therefore, stereochemical identity, specific optical rotation, isomeric purity, related substances, and batch-to-batch stereochemical consistency are important quality considerations during API qualification.
Gestodene also exhibits polymorphism.
Solid-state form control may be important during pharmaceutical development because crystal form and particle size characteristics can influence powder processing, content uniformity, dissolution behavior, and low-dose tablet manufacturing performance.
Pharmaceutical companies sourcing Gestodene API commonly evaluate assay, HPLC purity, identification, specific rotation, related substances, isomeric impurities, residual solvents, water content, polymorphic form, particle size distribution, and batch-to-batch consistency.
Because Gestodene is used at very low dose levels in hormonal contraceptive formulations, particle size distribution, API homogeneity, blending characteristics, and content-uniformity performance may be particularly important during oral tablet formulation development.
Swapnroop Drugs and Pharmaceuticals supplies Gestodene API for qualified pharmaceutical research, hormonal contraceptive development, reproductive health pharmaceutical formulations, analytical requirements, generic pharmaceutical development, and regulated manufacturing requirements with product-specific quality documentation, pharmaceutical-grade packaging, and reliable supply-chain coordination.
Pharmaceutical companies evaluating Gestodene API commonly focus on:
Stereochemical control is particularly important for Gestodene because its pharmacological and physicochemical characteristics are associated with a defined steroidal configuration.
Gestodene exhibits isomerism and polymorphism.
Therefore, isomeric purity and polymorphic-form consistency should be evaluated according to the applicable pharmacopoeial and approved product specification.
Particle size may also be an important quality attribute for Gestodene because the API is associated with low-dose oral contraceptive formulations.
Gestodene API is primarily associated with:
Gestodene is commonly associated with combined oral contraceptive formulations containing Ethinylestradiol.
Gestodene is a synthetic progestin associated with combined hormonal contraceptive pharmaceutical products.
Its progestogenic activity is mediated primarily through interaction with progesterone receptors.
Pharmaceutical companies evaluating Gestodene API may review:
Product-specific API specifications should be evaluated according to the intended dosage form, API concentration, manufacturing process, target regulatory market, and approved pharmaceutical development requirements.
Gestodene is a synthetic progestogen with activity at progesterone receptors.
Activation of progesterone receptor-mediated pathways produces progestogenic effects.
In combined hormonal contraceptive formulations, progestogenic activity contributes to suppression of the hormonal processes associated with ovulation.
Gestodene-related contraceptive activity is also associated with changes in cervical mucus and endometrial characteristics.
These pharmacological effects contribute to the contraceptive activity of Gestodene-containing combination pharmaceutical products.
Gestodene is commonly formulated with an estrogen such as Ethinylestradiol in combined oral contraceptive tablets.
Gestodene exhibits polymorphism and isomerism.
European pharmaceutical assessment documentation describes the use of Gestodene polymorphic Form I in pharmaceutical drug-substance manufacturing.
Solid-state characterization may include:
Polymorphic-form consistency should be evaluated according to the approved API and finished-product development strategy.
Changes in solid-state characteristics may influence pharmaceutical processing and formulation performance.
Gestodene is associated with low-dose hormonal contraceptive oral tablet formulations.
Low-dose API formulation development requires careful control of material and manufacturing characteristics.
Important development considerations may include:
Because Gestodene may be present at microgram-level quantities in contraceptive formulations, homogeneous API distribution throughout the tablet blend is an important formulation-development consideration.
Gestodene is commonly associated with combined oral contraceptive pharmaceutical products containing Ethinylestradiol.
Combination product development considerations may include:
The exact Gestodene and Ethinylestradiol strengths should be evaluated according to the intended product, approved formulation, and target regulatory market.
Swapnroop Drugs and Pharmaceuticals supports qualified pharmaceutical and hormonal drug-development customers with:
Gestodene API is supplied in secure pharmaceutical-grade packaging selected according to product quantity, potency, stability requirements, light-protection requirements, and customer specifications.
Product-appropriate pharmaceutical-grade inner liners and approved outer containers or HDPE drums may be used according to the supplied material specification.
Available packaging configurations may include:
Packaging configuration, MOQ, commercial quantity, polymorphic-form requirements, particle size requirements, and shipment conditions are confirmed according to the approved product specification and customer enquiry.
Store Gestodene API in tightly closed and appropriately labeled containers under the storage conditions specified in the approved product documentation.
Protect the material from contamination and unsuitable environmental exposure.
Handling should be performed by trained personnel using approved potent pharmaceutical and hormonal API handling procedures, appropriate personal protective equipment, containment controls, and applicable safety documentation.
Product-specific storage and handling requirements should be confirmed from the approved COA, SDS, pharmacopoeial specification, and stability documentation.
Swapnroop Drugs and Pharmaceuticals provides Gestodene API bulk supply and export coordination in India for qualified pharmaceutical manufacturers, hormonal contraceptive formulation companies, reproductive health pharmaceutical organizations, generic drug manufacturers, analytical laboratories, research organizations, and pharmaceutical procurement customers.
For Gestodene API price, CAS No. 60282-87-3, Ph. Eur. grade requirements, HPLC purity, stereochemical purity, specific rotation, polymorphic form, particle size requirements, COA availability, MOQ, packaging, and export enquiries, contact our pharmaceutical sales team.
Get Bulk Quote via WhatsApp